Skip to main content
. 2020 Dec 7;10:21353. doi: 10.1038/s41598-020-78603-9

Figure 2.

Figure 2

Survival curve of the continuous treatment maintenance rate of mesalazine granule preparation. (A) Overall. (B) Comparison between the good compliance group (dotted line) and the poor compliance group (solid line).